Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep-Oct;21(5):507-514.
doi: 10.1016/j.bjid.2017.04.004. Epub 2017 May 21.

Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in Salvador, Brazil

Mónica Narváez Betancur  1 , Liliane Lins  2 , Irismar Reis de Oliveira  2 , Carlos Brites  3
Affiliations

Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in Salvador, Brazil

Mónica Narváez Betancur et al. Braz J Infect Dis. 2017 Sep-Oct.

Abstract

The introduction of highly active antiretroviral therapy marked a major gain in efficacy of HIV/AIDS treatment and a reduction in morbidity and mortality of the infected patients. However, high levels of adherence are required to obtain virologic suppression. In Brazil, the policy of free and universal access to antiretroviral therapy has been in place since 1996, although there are reports of poor adherence.

Objective: To define the clinical, demographic and psychological characteristics, and quality of life of patients with HIV/AIDS who present poor adherence to highly active antiretroviral therapy.

Methods: This was a cross-sectional study. To be included in the study patients had to be 18 through 65 years old, diagnosed with HIV/AIDS, having the two previous viral loads above 500 copies, a surrogate for poor adherence to antiretrovirals. The following instruments were applied to all eligible patients: the sociodemographic questionnaire "Adherence Follow-up Questionnaire", the Beck Depression Inventory (BDI-II), the Beck Anxiety Inventory (BAI), and the 36-Item Short Form Survey.

Results: 47 patients were evaluated, 70.2% were female, mean age of 41.9 years (±10.5), 46.8% were single, 51.1% self-reported adherence ≥95%, 46.8% mentioned depression as the main reason for not taking the medication, 59.5% presented symptoms of moderate to severe depression, and 44.7% presented symptoms of moderate to severe anxiety. Finally, regarding health-related quality of life these patients obtained low scores in all dimensions, physical component summary of 43.96 (±9.64) and mental component summary of 33.19 (±13.35).

Conclusion: The psychological component is considered to be fundamental in the management of HIV/AIDS patients. Psychoeducation should be conducted at the initial evaluation to reduce negative beliefs regarding antiretroviral therapy Assessment of anxiety and depression symptoms should be done throughout therapy as both psycological conditions are associated with patient adherence, success of treatment, and ultimately with patients' quality of life.

Keywords: Adherence; Anxiety; Depression; HIV/AIDS; Highly active antiretroviral therapy; Nonadherence; Quality of life.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Summary of the selection process of HIV-AIDS patients presenting poor adherence to HIV therapy in Salvador-Brazil.
Fig. 2
Fig. 2
Reasons for stopping therapy among HIV/AIDS patients who present poor adherence to HAART, in Salvador, Brazil.
See this image and copyright information in PMC

References

    1. BRASIL. Congresso Nacional. Lei n° 9.313, 13 de novembro de 1996. Dispõe sobre a distribuição gratuita de medicamentos aos portadores do HIV e doentes de AIDS. Diário Oficial [da República Federativa do Brasil], Brasília, DF. (14 de nov 1996).
    1. Ministerio da Saúde . Departamento de DTS, Aids e Hepatites Virais; Brasilia: 2013. Secretaria de Vigilância em Saúde. Protocolo clínico e diretrizes terapêuticas para manejo da infecção pelo HIV em adultos. p. 216.
    1. Günthard H.F., Saag M.S., Benson C.A., et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society–USA panel. JAMA. 2016;316:191–210. - PMC - PubMed
    1. Bangsberg D.R., Perry S., Charlebois E.D., et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–1183. - PubMed
    1. Thompson M.A., Aberg J.A., Hoy J.F., et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the international antiviral society–USA panel. JAMA. 2012;308:387–402. - PubMed

MeSH terms

Substances